Mutant adenovirus type 9 E4 ORF1 genes define three protein regions required for transformation of CREF cells

Human adenovirus type 9 (Ad9) elicits exclusively estrogen-dependent mammary tumors in rats, and an essential oncogenic determinant for this virus is Ad9 E4 open reading frame 1 (9ORF1), which encodes a 125-residue cytoplasmic protein with cellular growth-transforming activity in vitro. In this study, we engineered 48 different mutant 9ORF1 genes in an attempt to identify regions of this viral protein essential for transformation of the established rat embryo fibroblast cell line CREF. In initial assays with CREF cells, 17 of the 48 mutant 9ORF1 genes proved to be severely defective for generating transformed foci but only 7 of these defective genes expressed detectable amounts of protein. To further examine the defects of the seven mutant proteins, we selected individual cell pools of stable CREF transformants for the wild-type and mutant 9ORF1 genes. Compared to cell pools expressing the wild-type 9ORF1 protein, most cell pools expressing mutant proteins displayed decreased growth in soft agar, and all generated significantly smaller tumors in syngeneic animals. The altered amino acid residues of the seven mutant 9ORF1 polypeptides clustered within three separate regions referred to as region I (residues 34 to 41), region II (residues 89 to 91), and C-terminal region III (residues 122 to 125). By using indirect immunofluorescence, we also assessed whether the mutant proteins localized properly to the cytoplasm of cells. The region I and region II mutants displayed approximately wild-type subcellular localizations, whereas most region III mutants aberrantly accumulated within the nucleus of cells. In summary, we have identified three 9ORF1 protein regions necessary for cellular transformation and have demonstrated that C-terminal region III sequences significantly influence the proper localization of the 9ORF1 polypeptide in cells.

[1]  B. Prasad,et al.  Human adenovirus early region 4 open reading frame 1 genes encode growth-transforming proteins that may be distantly related to dUTP pyrophosphatase enzymes , 1997, Journal of virology.

[2]  M. Rao,et al.  Cloning and Identification of Rat Deoxyuridine Triphosphatase as an Inhibitor of Peroxisome Proliferator-activated Receptor α* , 1996, The Journal of Biological Chemistry.

[3]  P. Nyman,et al.  Crystal structure of the Escherichia coli dUTPase in complex with a substrate analogue (dUDP) , 1996, Nature Structural Biology.

[4]  M. McArthur,et al.  Human adenovirus type 9 E4 open reading frame 1 encodes a cytoplasmic transforming protein capable of increasing the oncogenicity of CREF cells , 1996, Journal of virology.

[5]  D. Green,et al.  The killer and the executioner: how apoptosis controls malignancy. , 1995, Current opinion in immunology.

[6]  D. DiMaio,et al.  Mutational analysis of the interaction between the bovine papillomavirus E5 transforming protein and the endogenous beta receptor for platelet-derived growth factor in mouse C127 cells , 1995, Journal of virology.

[7]  D. Fisher Apoptosis in cancer therapy: Crossing the threshold , 1994, Cell.

[8]  R. Javier Adenovirus type 9 E4 open reading frame 1 encodes a transforming protein required for the production of mammary tumors in rats , 1994, Journal of virology.

[9]  T. Shenk,et al.  Requirement for the adenovirus type 9 E4 region in production of mammary tumors. , 1992, Science.

[10]  J. Pipas Common and unique features of T antigens encoded by the polyomavirus group , 1992, Journal of virology.

[11]  E. Fanning,et al.  Simian virus 40 large T antigen: the puzzle, the pieces, and the emerging picture , 1992, Journal of virology.

[12]  Zbigniew Dauter,et al.  Crystal structure of a dUTPase , 1992, Nature.

[13]  X P Zhang,et al.  Random mutagenesis of gene-sized DNA molecules by use of PCR with Taq DNA polymerase. , 1991, Nucleic acids research.

[14]  T. Shenk,et al.  Human adenovirus type 9-induced rat mammary tumors , 1991, Journal of virology.

[15]  B. Vogelstein,et al.  Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[16]  P. Anthony,et al.  Chlamydia , 1990 .

[17]  J. Ankerst,et al.  Adenovirus type 9-induced tumorigenesis in the rat mammary gland related to sex hormonal state. , 1989, Journal of the National Cancer Institute.

[18]  J. Trowsdale,et al.  Analysis of HLA-DR glycoproteins by DNA-mediated gene transfer. Definition of DR2 beta gene products and antigen presentation to T cell clones from leprosy patients , 1988, The Journal of experimental medicine.

[19]  E. Moran,et al.  Multiple functional domains in the adenovirus E1A gene , 1987, Cell.

[20]  P. Fisher,et al.  Analysis of type 5 adenovirus transformation with a cloned rat embryo cell line (CREF). , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[21]  V. Freedman,et al.  Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[22]  V. Freedman,et al.  Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. , 1974, Cell.

[23]  E. Norrby,et al.  Induction of mammary fibroadenomas in rats by adenovirus type 9 , 1974, International journal of cancer.

[24]  R. Dulbecco Cell transformation by viruses. , 1969, Science.

[25]  E. Wagner,et al.  Oncogenic properties of the middle T antigens of polyomaviruses. , 1994, Advances in cancer research.

[26]  D. Goeddel,et al.  A method for random mutagenesis of a defined DNA segment using a modified polymerase chain reaction , 1989 .

[27]  F. Graham Transformation by and Oncogenicity of Human Adenoviruses , 1984 .

[28]  S. Robbins,et al.  Pathologic basis of disease , 1974 .